Clinical and pathological phenotypes of LRP10 variant carriers with dementia

Manuscript Number: 

20-0318R1

Author(s): 
Vincenzo Bonifati, Guido Breedveld, Hanneke Geut, Demy J.S. Kuipers, Marialuisa Quadri, Annemieke J. Rozemuller, Leonie J.M. Vergouw, Frank Jan de Jong, John C. van Swieten, Wilma D.J. van de Berg

Disclosures

Vincenzo Bonifati

  • Nothing to Disclose

Guido Breedveld

  • Nothing to Disclose

Frank Jan de Jong

  • Nothing to Disclose

Hanneke Geut

  • Nothing to Disclose

Demy J.S. Kuipers

  • Nothing to Disclose

Marialuisa Quadri

  • Nothing to Disclose

Annemieke J. Rozemuller

  • Nothing to Disclose

Wilma D.J. van de Berg

  • Consulting Fees:
    Consulting fees from Lysosomal Therapeutics
    Lecture Fees:
    Lecture fee from Roche Pharma Research and Early Development, F. Hoffmann-La Roche Ltd.
    Grants
    • Agency: 
      Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche
      Dates: 
      2014, 2019
    • Agency: 
      Lysosomal Therapeutics Inc., Cambridge USA
      Dates: 
      2018
    • Agency: 
      Crossbeta Sciences, The Netherlands
      Dates: 
      2019
    • Agency: 
      Lundbeck, Denmark
      Dates: 
      2019

John C. van Swieten

  • Consulting Fees:
    Lundbeck, one-day meeting about potential tau trial visit in december 2019

Leonie J.M. Vergouw

  • Nothing to Disclose